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Study Objectives

Clinical guidelines from professional societies suggest that
outpatient management is safe for low-risk patients with
venous thromboembolism (VTE). With FDA approval of
direct oral anticoagulants (DOACs), there has been a shift
in treating low-risk VTE patients with DOACs to the
outpatient setting. This study sought to describe sex
specific differences in the management of VTE.

Methods

We performed a retrospective analysis on a quality
improvement database of a convenience sample of those
diagnosed with VTE between 9/1/2020-2/28/2021. Patients
were included if they were evaluated in the ED at one of
6 network hospitals in NE Pennsylvania: 3 rural community
hospitals, a Level 1 trauma/academic center, a suburban
hospital and a center city hospital.
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Results

From 9/1/20-2/28/21, 454 patients, 219 female (48.2%) and 235 (51.8%) male with
an average age respectively of 61 and 58 years, were diagnosed with VTE. Of
these, 248 (54.6%) were admitted for VTE treatment and 206 (45.4%) were
discharged. The length of stay (LOS) range for the female group was 37-2776
minutes (average of 389 minutes) vs. a range of 70-1545 minutes (average of 396
minutes) for the male group. Regarding disposition, 127 (57.9%) females were
admitted and 92 (42.0%) were discharged vs. 121 (51.5%) males admitted and 114
(48.5%) discharged (p=0.164). Twenty-seven (12.3%) of the female patients and 33
(14.0%) of the males didn’t have a follow-up appointment scheduled at discharge
(p=0.590). There were 27 patients that returned within 30 days with a VTE
diagnosis, 13 were females and 14 were males (p=0.992). Of those who returned
that had been discharged, 9 were females (69.3%) compared to 4 (28.6%) males.
Of those who returned that had been admitted, 4 were females (30.7%) vs. 10
(71.4%) males. DOACs were prescribed to 127 (57.9%) female patients: 82 (64.6%)
receiving apixaban, 33 (25.9%) rivaroxaban, 7 (5.5%) enoxaparin and 5 (3.9%)
warfarin compared to 126 (53.6%) male patients: 65 (51.6%) receiving apixaban, 37
(29.4%) rivaroxaban, 18 (14.3%) enoxaparin and 6 (4.8%) warfarin.

Conclusion

Our study found that there were no statistically significant
sex specific differences in disposition of patients presenting
to the ED with VTE. Further study with a larger dataset to
determine the impact of these potential sex specific
differences in medication management on patient
outcomes as well as to elucidate the impact COVID has
on management is indicated.
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